ClinicalTrials.Veeva

Menu

Effect of Lidocaine/Dexamethasone on the Success of IANB

I

Isfahan University of Medical Sciences

Status and phase

Completed
Phase 3
Phase 2

Conditions

Local Anesthesia

Treatments

Drug: Dexamethasone
Drug: 2% lidocaine with 1:80,000 epinephrine
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this prospective, randomized, double-blind study was to compare the success rate of IAN block injection carried out with two cartridges of 2% lidocaine with 1:80000 epinephrine each combined with 0.2 ml dexamethasone versus two cartridges of 2% lidocaine with 1:80000 epinephrine each combined with 0.2 ml sterile distilled water for endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

Full description

Several investigations have been carried out to demonstrate the effect of dexamethasone added to local anesthetics in regional block injections. These investigations shown that the addition of dexamethasone to local anaesthetics may prolong the duration of anesthesia and also results in a faster onset. It is hypothesized that dexamethasone added to lidocaine may affect the success rate of inferior alveolar nerve block

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • vital mandibular molar tooth
  • diagnosis of symptomatic irreversible pulpitis

Exclusion criteria

  • younger than 18 years old
  • history of significant medical conditions
  • allergies to local anesthetics or sulfites
  • pregnancy
  • taking any medications that might influence anesthetic assessment
  • active sites of pathosis in area of injection
  • inability to give informed consent

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups, including a placebo group

Dexamethasone
Experimental group
Description:
lidocaine \& Dexamethasone
Treatment:
Drug: 2% lidocaine with 1:80,000 epinephrine
Drug: Dexamethasone
Non-dexamethasone
Placebo Comparator group
Description:
lidocaine \& Placebo
Treatment:
Drug: Placebo
Drug: 2% lidocaine with 1:80,000 epinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems